Obese Patients with Sleep Apnea Syndrome Treated by Progesterone

Two obese patients with sleep apnea syndrome were administered chlormadinone acetate (CMA), a synthetic progesterone, known as a potent respiratory stimulant to augment load compensation response as well as CO2 chemosensitivity. Before CMA administration, both cases showed normal chemosensitivity of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Tohoku Journal of Experimental Medicine 1988, Vol.156(Suppl), pp.151-157
Hauptverfasser:	KIMURA, HIROSHI, TATSUMI, KOUICHIRO, KUNITOMO, FUMIO, OKITA, SHINYA, TOJIMA, HIROKAZU, KOUCHIYAMA, SHIRO, MASUYAMA, SHIGERU, SHINOZAKI, TOSHIHIDE, MIKAMI, MAKOTO, WATANABE, SHOHEI, ISHIKAWA, YOU, HONDA, YOSHIYUKI, KURIYAMA, TAKAYUKI
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Blood Gas Analysis Chlormadinone Acetate - therapeutic use Electrocardiography Electroencephalography Electromyography Electrooculography Humans load compensation Male Middle Aged Obesity - complications obstructive sleep apnea progesterone sleep apnea syndrome Sleep Apnea Syndromes - blood Sleep Apnea Syndromes - drug therapy Sleep Apnea Syndromes - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!